Published in Adv Exp Med Biol on January 01, 2007
Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A (2005) 2.82
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol (2007) 2.77
Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects. Dig Dis Sci (2006) 1.81
A key role of dendritic cells in probiotic functionality. PLoS One (2007) 1.73
Pseudomonas aeruginosa population structure revisited. PLoS One (2009) 1.68
Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol Ecol (2005) 1.50
Yersinia pseudotuberculosis harbors a type IV pilus gene cluster that contributes to pathogenicity. Infect Immun (2002) 1.49
Feeding our immune system: impact on metabolism. Clin Dev Immunol (2008) 1.42
Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl Environ Microbiol (2006) 1.42
The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence. Infect Immun (2004) 1.34
Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2). J Thorac Oncol (2012) 1.32
Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A (2010) 1.29
Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res (2010) 1.27
High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg (2006) 1.22
YAPI, a new Yersinia pseudotuberculosis pathogenicity island. Infect Immun (2004) 1.20
Transcriptome analysis of Yersinia pestis in human plasma: an approach for discovering bacterial genes involved in septicaemic plague. Microbiology (2007) 1.19
Functional analysis of D-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG. Appl Environ Microbiol (2007) 1.17
Autophagosomes can support Yersinia pseudotuberculosis replication in macrophages. Cell Microbiol (2010) 1.16
Mechanisms involved in alleviation of intestinal inflammation by bifidobacterium breve soluble factors. PLoS One (2009) 1.15
The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis. J Bacteriol (2002) 1.14
Nod-like receptors: cytosolic watchdogs for immunity against pathogens. PLoS Pathog (2007) 1.12
Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv Appl Microbiol (2004) 1.11
Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine (2003) 1.10
Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models. Int J Food Microbiol (2007) 1.10
Promising immunomodulatory effects of selected strains of dairy propionibacteria as evidenced in vitro and in vivo. Appl Environ Microbiol (2010) 1.06
Recombinant lactic acid bacteria as mucosal biotherapeutic agents. Trends Biotechnol (2011) 1.05
Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Gastroenterology (2007) 1.05
Probiotics from research to market: the possibilities, risks and challenges. Curr Opin Microbiol (2013) 1.05
Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLoS One (2012) 1.04
Chemical extraction versus direct smear for MALDI-TOF mass spectrometry identification of anaerobic bacteria. Anaerobe (2012) 1.03
Probiotics, prebiotics, and the host microbiome: the science of translation. Ann N Y Acad Sci (2013) 1.01
Complete genome sequence of the dairy isolate Streptococcus macedonicus ACA-DC 198. J Bacteriol (2012) 0.99
Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann N Y Acad Sci (2014) 0.98
How can probiotics and prebiotics impact mucosal immunity? Gut Microbes (2010) 0.98
Discussion on toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology (2004) 0.98
Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice. World J Gastroenterol (2010) 0.98
Phenotypic analysis of Yersinia pseudotuberculosis 32777 response regulator mutants: new insights into two-component system regulon plasticity in bacteria. Int J Med Microbiol (2007) 0.95
NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation. Trends Microbiol (2006) 0.95
Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model. Int J Food Microbiol (2009) 0.94
Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome. Am J Respir Crit Care Med (2014) 0.93
Bioluminescence imaging study of spatial and temporal persistence of Lactobacillus plantarum and Lactococcus lactis in living mice. Appl Environ Microbiol (2012) 0.93
The Yersinia pseudotuberculosis Yut protein, a new type of urea transporter homologous to eukaryotic channels and functionally interchangeable in vitro with the Helicobacter pylori UreI protein. Mol Microbiol (2002) 0.93
Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response. Infect Immun (2013) 0.93
Sudden onset of pseudotuberculosis in humans, France, 2004-05. Emerg Infect Dis (2008) 0.92
Comparative genomics of the dairy isolate Streptococcus macedonicus ACA-DC 198 against related members of the Streptococcus bovis/Streptococcus equinus complex. BMC Genomics (2014) 0.91
Gut microbiota limits heavy metals burden caused by chronic oral exposure. Toxicol Lett (2013) 0.91
Growth of Yersinia pseudotuberculosis in human plasma: impacts on virulence and metabolic gene expression. BMC Microbiol (2008) 0.91
Ecotoxicology inside the gut: impact of heavy metals on the mouse microbiome. BMC Pharmacol Toxicol (2013) 0.89
Health claims substantiation for probiotic and prebiotic products. Gut Microbes (2011) 0.89
Genes encoding specific nickel transport systems flank the chromosomal urease locus of pathogenic yersiniae. J Bacteriol (2002) 0.89
Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts. Anticancer Drugs (2010) 0.89
Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV. Vaccine (2009) 0.89
Biodiversity of lactic acid bacteria in Romanian dairy products. Syst Appl Microbiol (2005) 0.88
Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract. Appl Environ Microbiol (2013) 0.87
High Resolution Typing by Whole Genome Mapping Enables Discrimination of LA-MRSA (CC398) Strains and Identification of Transmission Events. PLoS One (2013) 0.87
Preclinical assessment of cisplatin-based therapy versus docetaxel-based therapy on a panel of human non-small-cell lung cancer xenografts. Anticancer Drugs (2009) 0.87
Contribution of surface β-glucan polysaccharide to physicochemical and immunomodulatory properties of Propionibacterium freudenreichii. Appl Environ Microbiol (2012) 0.87
Defensins couple dysbiosis to primary immunodeficiency in Crohn's disease. World J Gastroenterol (2011) 0.87
Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse. Infect Immun (2004) 0.86
[SIMS REIN: a multi-source information system for end-stage renal disease]. C R Biol (2002) 0.85
Molecular diagnosis of endocarditis due to Lactobacillus casei subsp. rhamnosus. Clin Infect Dis (2002) 0.85
Similarities of Kawasaki disease and Yersinia pseudotuberculosis infection epidemiology. Pediatr Infect Dis J (2007) 0.85
Two-component system regulon plasticity in bacteria: a concept emerging from phenotypic analysis of Yersinia pseudotuberculosis response regulator mutants. Adv Exp Med Biol (2007) 0.85
Recommended minimal standards for description of new taxa of the genera Bifidobacterium, Lactobacillus and related genera. Int J Syst Evol Microbiol (2014) 0.85
Beneficial effect of probiotics in IBD: are peptidogycan and NOD2 the molecular key effectors? Gut Microbes (2011) 0.84
Interlaboratory diagnostic validation of conformation-sensitive capillary electrophoresis for mutation scanning. Clin Chem (2010) 0.84
Chronic ingestion of cadmium and lead alters the bioavailability of essential and heavy metals, gene expression pathways and genotoxicity in mouse intestine. Arch Toxicol (2013) 0.83
An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteriemia in hematology patients. Haematologica (2006) 0.83
Macedovicin, the second food-grade lantibiotic produced by Streptococcus macedonicus ACA-DC 198. Food Microbiol (2012) 0.83
Microbial characterization of probiotics--advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC). Mol Nutr Food Res (2013) 0.83
Characterization of pLAC1, a cryptic plasmid isolated from Lactobacillus acidipiscis and comparative analysis with its related plasmids. Int J Food Microbiol (2010) 0.83
Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics. Ann N Y Acad Sci (2014) 0.83
Hypoxic single-pass isolated hepatic perfusion of hypotonic Cisplatin: safety study in the pig. Ann Surg Oncol (2009) 0.82
Cytokine-regulated expression and inhibitory function of FcgammaRIIB1 and -B2 receptors in human dendritic cells. J Leukoc Biol (2005) 0.82